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In 1990, an association between thyroid antibody positivity and spontaneous miscarriage was ﬁrst reported. A generation has
passed since the initial observation. Over that time a robust literature has developed which has conﬁrmed the initial ﬁnding
and expanded upon it. The present paper reviews the literature that has been generated over the last twenty years on the
following topics: (1) thyroid antibodies and spontaneous miscarriage, (2) thyroid antibodies and recurrent abortion, (3) etiology
of pregnancy loss in thyroid antibody positive women, and (4) discussionof future research directions.
1.Introduction
It has been twenty years since the ﬁrst paper reporting
an association between thyroid antibodies and spontaneous
miscarriage in euthyroid women was published [1]. The
ﬁnding was serendipitous as the study was designed to
evaluate the prevalence and etiology of postpartum thy-
roiditis. Five hundred and ﬁfty-two women in the New
York metropolitan area were screened in the ﬁrst trimester
of pregnancy for thyroid function and thyroid antibody
status. A cohort of antibody positive and antibody negative
women were selected and followed prospectively throughout
pregnancy and into the postpartum period. As the study
progressed, a high incidence of spontaneous miscarriage
was observed in the cohort. In particular, it appeared
that the miscarriage rate was disproportionately higher in
women who were thyroid antibody positive. Followingmuch
discussion within the research team, as there was no known
association between thyroid autoimmunity and miscarriage,
nor was there a plausible mechanism, it was decided to
examine thepregnancy outcomein the552womenwho were
initially screened. A doubling of the miscarriage rate was
found (17% versus 8.4%, P = .011) and reported in the
Journal of the American Medical Association. It was unclear
at the time if the ﬁnding was a statistical ﬂuke or in fact
represented an important association.
A generation has passed since the initial observation.
Over that time a robust literature has developed which has
not only conﬁrmed the initial observation but expanded
upon it. The present paper will summarize the data that has
beenpublished overthe ensuing 20 years and speculate upon
future directions. In particular, the areas of focus will be (1)
thyroid antibodies and spontaneous miscarriage, (2) thyroid
antibodies and recurrent abortion, (3) etiology of pregnancy
loss, and (4) future directions. A comprehensive meta-
analysis was published last year on the relationship between
thyroid antibodies and in vitro fertilization (IVF) demon-
strating that thyroid autoimmunity in women undergoing
IVF is associated with an increased rate of pregnancy loss
[2]. Consequently, the present discussion will not include
a review of the IVF and thyroid antibody literature on
spontaneous miscarriage.
2.Thyroid Antibodiesand PregnancyLoss
As noted above, Stagnaro-Green et al. reported a statistically
signiﬁcant doubling in the miscarriage rate in American
euthyroid women in the ﬁrst trimester of pregnancy who2 Journal of Thyroid Research
were thyroid antibody positive. Of the 552 women initially
screened, 57 were unavailable for followup. One hundred
women were thyroid antibody positive (with a miscarriage
rate of 17/100 or 17%), and 392 women were antibody
negative (with a miscarriage rate of 33/392 or 8.4%). Prior
to the 1990 paper the only antibody shown to be associated
with spontaneous miscarriage was anticardiolipin antibody.
Analysis of the sera of the 50 women who miscarried
revealed no diﬀerence in percentage of women who were
cardiolipin antibody positive between women who were
thyroid antibody positive and miscarried versus women
who were thyroid antibody negative and miscarried. There
were also no demographic diﬀerences between the groups.
The TSH level was slightly, but not signiﬁcantly, higher
in the thyroid antibody positive women as compared to
thyroid antibody negative controls (TSH-2.35mIU/L versus
1.60mIU/L, resp., P = .1 2 ) .F i n a l l y ,n od i ﬀerence in thyroid
antibody titers were noted in antibody positive women who
miscarried as compared to antibody women who carried to
term.
Glinoer and colleagues in 1991 [3]r e p o r t e dﬁ n d i n g s
of a prospective study of 120 Belgian euthyroid women
with mild thyroid abnormalities (nodules, goiter or thyroid
antibody positivity) and 630 euthyroid controls. The goal
of the study was to evaluate the progression of thyroid
function tests throughout pregnancy and assess for adverse
obstetrical and/or neonatal outcomes. Women with thyroid
autoimmunity (n = 45) were found to have a dramatic
increase in spontaneous miscarriage when contrasted to
controls (13.3% versus 3.3%, P<. 001). As found in the
study by Stagnaro-Green et al. there was no association with
anticardiolipin antibody or thyroid antibody titer. Further
analysis of the study was published by Lejeune et al. in 1993
[4]. Speciﬁcally, analysis of ﬁrst trimester pregnancy loss
revealed a spontaneous miscarriage rate of 24% in thyroid
antibody positive women when compared to 5% in controls
(P<. 005).
In 1997, Iijima and colleagues evaluated 1179 healthy
pregnant Japanese women between 6-14 weeks gestation for
the presence of seven autoantibodies [5]. A doubling of
the miscarriage rate was reported in antithyroid microsomal
antibody positive women as contrasted to women who were
negative for all seven autoantibodies (10.4% versus 5.5%,
resp., P<. 0 5 ) .F u r t h e r m o r e ,t h er a t eo fs m a l lf o rg e s t a t i o n a l
age births (SGA) was increased in microsomal antibody
women when compared to controls (7.1% versus 3.4%).
The thyroid antibody titer was related to neither the rate of
spontaneous miscarriage nor the rate of SGA.
Bagis and colleagues published a study of 876 Turkish
women initially screened at 12 weeks gestation [6]. All
women had thyroid function tests and thyroid autoantibod-
ies performed at 12 weeks gestation, revealing an antibody
positive rate in the entire cohort of 12.3% (P<. 0001).
Fifty percent of the antibody-positive group had a history
of a prior miscarriage as contrasted to only 14.1% in
the antibody negative group (P<. 0001). TSH levels
were signiﬁcantly higher in antibody-positive women with
a history of miscarriage as compared to antibody women
who had carried to term (1.90μU/mL versus 1.2μU/mL,
P<. 006). Free T4 values were also lower in the antibody
positive women with a history of miscarriage (11.0pmol/L
versus 12.7pmol/L, P<. 05).
In 2006, Ghafoor et al. evaluated 1500 Pakistani women
for thyroid peroxidase antibodies and thyroid function
tests during pregnancy. Women were followed throughout
gestation to determine pregnancy outcome [7]. Thyroid
antibody positive women, which comprised 11.2% of the
cohort, had a spontaneous miscarriage rate of 36.3% as
compared to 1.8% in antibody negative women (P<. 01).
A signiﬁcantly higher rate of prematurity was also reported
(26.8% versus 8.0, P<. 01) in antibody positive women. All
1500 women in the study were euthyroid.
In 2006, Negro et al. reported the ﬁndings of a prospec-
tive interventiontrial. Nine hundred and eighty-fourwomen
from southern Italy in the ﬁrst trimester of pregnancy
were evaluated for thyroid function and thyroid peroxidase
[8]. Women who were antibody positive (n = 115) were
divided into two groups. Half of the antibody positive
women were given levothyroxine during pregnancy (n =
57), the dose of which was determined by their initial TSH
level and thyroid antibody titer. The remaining antibody
positive women (n = 58), along with 869 antibody negative
controls, did not receive levothyroxine intervention. The
rate of spontaneous miscarriage was 13.8% in untreated
thyroid antibody positive women and 2.4% in the 890
controls (P<. 05). Thyroid antibody positive women who
received levothyroxinehad a spontaneous miscarriage rate of
3.5% which was similar to controls (2.4%), and statistically
lower then the miscarriage rate in the untreated thyroid
antibody positivegroup(13.8%)(P<. 05).Thyroid antibody
positive women who were not treated with levothyroxine
had higher TSH levels at 20 weeks, 30 weeks, and three
days postdelivery when compared to controls or thyroid
antibody-positive women who were given levothyroxine.
The largest diﬀerencewas seenpostdelivery (TSH-1.9mIU/L
in levothyroxine treated antibody positive women, TSH-
3.5mIU/L in untreated antibody positive women, TSH-
2.1mIU/L in controls, P<. 01). Free T4 values were also
lower in the untreated group at 30 weeks and postdelivery
when compared to treated antibody positive women or
controls (postdelivery values were 10.2ng/liter, 14.3ng/liter,
and 14.6ng/liter, resp., P<. 01)
In summary, a total of seven studies (see Table 1)i n
six diﬀerent countries have reported an association between
thyroid antibody positivity in unselected women in the ﬁrst
trimester of pregnancy and spontaneous miscarriage (see
Figure 1). It can therefore be concluded that there is a clear
and consistent association between thyroid antibody posi-
tivity and pregnancy loss. Studies have excluded cardiolipin
antibody as a potential explanation for the pregnancy loss.
3.RecurrentAbortion
Shortly after the initial publication demonstrating an asso-
ciation between thyroid antibody positivity and sponta-
neous miscarriage, researchers began evaluatingwomenwith
recurrent abortion. Recurrent abortion occurs in 0.5–1%Journal of Thyroid Research 3
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Figure 1: Percentage of spontaneous miscarriage in unselected pregnancies in women who were thyroid antibody positive (TAb+) and
thyroid antibody negative (TAB−).
Table 1: Country of origin and number of women in each study of
Figure 1.
Author Country TAb+ TAb−
Stagnaro-Green et al. [1] USA 100 392
Glinoer et al. [3] Belgium 45 360
Lejeune et al. [4] Belgium 23 340
Iijima et al. [5] Japan 24 52
Bagis et al. [6] Turkey 108 768
Ghafoor et al. [7] Pakistan 212 1288
Negro et al. [8] Italy 115 869
of all women and is deﬁned as three or more spontaneous
miscarriages. The etiology is multifactorial, and includes
uterine anomalies, endocrine disorders, genetic defects, and
the anticardiolipin antibody. Nevertheless, despite com-
prehensive workups, approximately 50% of women with
recurrent abortion will have no identiﬁed etiology. It is
therefore not surprising that multiple research groups have
studied the relationship between thyroid antibody positivity
in women with recurrent abortion.
The ﬁrst two studies investigating women with recurrent
abortion were published in 1993 and performed by Pratt
and colleagues in Chicago. The ﬁrst study examined 45
women with recurrent abortion for four polynucleotides,
ﬁve histones, six phospholipids, and thyroid antibodies [20].
Thirty-one percent of the recurrent aborters were thyroid
antibody positive as compared to 19% in a control group of
100 normal blood donors (P = ns). The study was limited
by the composition of the controls which included 46 men,
and the small size of the group of women with recurrent
abortion. Pratt and colleagues then performed a prospective
study evaluating the outcome of a subsequent pregnancy in
42womenwithrecurrentabortion[9].Thirty-one percentof
the 42 women were thyroid antibody positive (n = 13) with
12 of the 42 women experienced a recurrent abortion in the
subsequentpregnancy.Ofthetwelvewomenwhomiscarried,
eight were thyroid antibody positive (8/12 = 67%). In com-
parison, onlyﬁve ofthethirty who went totermwere thyroid
antibody positive (17%) (P = .003). The authors concluded
that in women with recurrent abortion the presence of
thyroid antibody positivity was associated with an increased
rate of pregnancy loss in a subsequent pregnancy.
Bussen and Steck also published two papers on the topic
of thyroid antibodies and recurrent abortion. The ﬁrst study
was published in 1995 and evaluated 66 German women
for thyroid antibody positivity. Three groups were studied,
including 22 euthyroid nonpregnant women with recurrent
abortion, 22 multigravida women without endocrine disor-
ders, and 22 nulligravida women [10]. The recurrent abor-
tion group had a signiﬁcantly higher rate of antibody posi-
tivity (36%) then either the euthyroid nonpregnant controls
(5%) (36% versus 5%, P<. 01), or the nulligravida controls
(9%) (36% versus 9%, P<. 01). In their 1997 paper, Bussen
and Steck evaluated 28 euthyroid nonpregnant women with
recurrent abortion for thyroid antibodies and nonorgan
speciﬁc antibodies [12]. Secondary causes of recurrent
abortion were excludedin all 28 women. Thirty-nine percent
(n = 11/28) of the women with recurrent abortion were
positive for thyroid antibodies versus 7% (n = 2/28) of
multigravida controls (P<. 01). No correlation was found
betweenthepresenceofphospholipidantibodiesandthyroid
antibody positivity.
In a small study performed by Roberts et al. in Scotland
in 1996, thyroid antibody positivity rate was evaluated in
11 women with recurrent abortion, 11 healthy pregnant
women, 10 nonpregnant women, 11 women with a spon-
taneous miscarriage, and 10 women who had an elective
termination of pregnancy [11]. Thirty-six percent (4/11) of
the women with a history of recurrent abortion were thyroid
antibody positive as opposed to ﬁve percent (2/41) of the
women in the other four groups (P<. 01). Roussev et
al. also performed a small study consisting of 45 women
with recurrent abortion and 15 healthy controls [21]. No
diﬀerence was found in the thyroid antibody positivity
rate between the two groups (9% versus 0%, P = ns).4 Journal of Thyroid Research
Interpretation of the results of both studies are limited by
their small sample size.
In 1998, Esplin et al. published a study performed in Salt
LakeCity, Utah comparing the incidenceof thyroid antibody
positivity in 74nonpregnant women with recurrent abortion
with 75 healthy nonpregnant controls of similar gravidity
[13]. Women included in the recurrent abortion group had
all tested negative for secondary causes of pregnancy loss.
Althoughthethyroidantibodypositivityrateintherecurrent
abortion group was elevated at 29% the control group had
an unusually high rate of thyroid antibody positivity of 37%
(P = ns). It is unclear if geographic diﬀerences in rates of
thyroid antibody positivity was a confound in this study.
In the largest study performed to date, Kutteh and
colleagues in 1999 compared the rate of thyroid antibody
positivity in 700 women with a minimum of two spon-
taneous miscarriages and in whom secondary causes of
pregnancy loss were excluded, to 200 healthy controls [14].
All sera were obtained at least three months following a
spontaneous miscarriage or birth. Thyroid antibody positive
rate was signiﬁcantly higher in the recurrent abortion group
when compared to the controls (22.5% versus 14.5%, P =
.01). There was no diﬀerence between the groups in regards
to percentage of women with abnormally elevated TSH
values; however women with a history of recurrent abortion
were older then controls (33.3 years versus 30.8 years, P<
.01).
Four more studies with either limited numbers of partic-
ipants,orlackofacontrolgroup,were publishedin1999and
2000. Rushworth et al. evaluated the pregnancy outcome of
24 antibody-positive euthyroid British women with a history
of recurrent abortion through a subsequent pregnancy.
Eighty-one thyroid antibody negative women with recurrent
abortionservedascontrols[22].Thelivebirthrateofthetwo
groupswasidenticalat58%.Althoughtheauthorsconcluded
that thyroid antibody positivity in women with recurrent
abortion does not portend a worse outcome when compared
to women who are thyroid antibody negative, interpretation
of the results are limited by the small number of thyroid
antibody positive women evaluated (n = 24). Reznikoﬀ-
Etievant et al. evaluated 678 French women with recurrent
abortion and found a prevalence rate of thyroid antibody
positivity of 2.9%. The study did not include a control
group and did not address the unusually low rate of thyroid
anitbody positivity [23]. Dendrinos et al. reported a thyroid
antibody positivity rate of 37% in 30 Greek women with
recurrent abortion as compared to 13% of 15 age-matched
controls (P<. 05) [15]. Finally, Mecacci reported that 37.9%
(11/29) of women with recurrent abortion were antithyroid
antibody positive as compared to 14.5% (10/69) of controls
(P<. 02) [16].
In 2002, Abdel Aziz et al. [24] performed a prospective
study that was similar in design to the second investigation
performed by Pratt et al. in 1993 [9]. Fifty Egyptian women
with a history of recurrent abortion were tested for thyroid
antibodies and followed until the 20th week of pregnancy.
Eighteen (36%) of the women had the presence of thyroid
antibodies. Twelve of the eighteen women (67%) went on to
haveanotherspontaneous miscarriage as comparedto15.6%
(5/32) of the thyroid antibody negative women (P<. 001).
These results are almost identical to the ﬁndings reported
by Pratt and colleagues [9]. Antibody-positive women were
older (33.1 years versus 29.0 years, P<. 01), had a larger
thyroid volume (23.9mL versus 19.3mL, P<. 001) and
reported a higher number of prior abortions (5.1 versus 3.9,
P<. 05) as compared to antibody-negative women.
A large scale study prospective trial comparing successful
pregnancy inthreegroupsofwomenwith recurrentabortion
was performed by De Carolis et al. in 2004 [25]. Group
1 consisted of women who were thyroid antibody positive
but antiphospholipid syndrome (APS) negative (n = 162),
group 2 women were APS positive but antithyroid antibody
negative (n = 149), and group 3 women were both APS and
thyroid antibody positive (n = 54).The group with the high-
est percentage of successful pregnancy outcome was Group 2
(92%), whereas the two groups of women who were thyroid
antibody positive had signiﬁcantly lower rates of successful
pregnancies (Group 1–57%, Group 3–60%, P = .0003).
Anotherstudypublishedin2004wasconductedbyMarai
et al. who evaluated 58 Israeli women [17]. Thirty-eight
of the women had a history of recurrent abortion and 20
women had a history of infertility but no pregnancy losses.
Thyroid antibody positivity rate was signiﬁcantly higher in
the women with recurrent abortion (21%) when compared
to the thyroid antibody positive rate in women witha history
of infertility (0%) (P = .001).
Shoenfeld and colleagues evaluated 109 women with
recurrent pregnancy loss and compared the rate of thyroid
antibody positivity to 120 healthy controls. Results on
the presence of thyroid peroxidase or antithyroglobulin
antibodies were only presented for 24 of the women with
recurrent abortion. Thirty-three percent of the 24 women
(8/24) were positive for thyroid antibodies as compared to
only 11.2% (14/120) of the healthy controls (OR-3.79 {CI-
1.2–11.7})[ 18].
The most recent papers on thyroid antibodies and
recurrent abortion were published in 2008. The ﬁrst was a
case control study performed by Iravani et al. [19]i nI r a n
which included 641 women with three or more consecutive
pregnancy losses and 269 age-matched controls. Women
in the recurrent abortion group had a rate of thyroid
antibody positivity almost twice that of the control group
(24.5% versus 12.6%, P<. 001). Mean TSH levels were
higher in the recurrent abortion group when compared
to controls (TSH-1.93mIU/L versus 1.3mIU/L, P<. 001)
and was independently associated with both pregnancy loss
and autoimmunity. In a much smaller study, Bellver et al.
found no diﬀerence in thyroid antibody positivity between
30 Spanish women with recurrent abortion and 32 controls
(3.6% versus 15.6%) [26].
In conclusion, there have been 17 studies performed to
date comparing thyroid antibody positivity rate in women
with recurrent abortion as compared to control groups. The
studies vary markedly in regards to the size ofthe population
studied and have taken place in ﬁve diﬀerent countries.
Thirteen of the seventeen studies performed demonstrated
a signiﬁcant increase in the thyroid antibody positivity rate
in women with recurrent abortion (Table 2, Figure 2). OfJournal of Thyroid Research 5
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Figure 2: Percentage of thyroid antibody positivity in women with recurrent abortion (Recurrent Ab) and controls.
interest, the three negative studies were all performed in the
United States.
4.EtiologyofPregnancyLoss
The etiology of pregnancy loss in thyroid antibody-positive
women remains to be elucidated. Two meta-analyses have
reported a diﬀerence in the mean age and mean TSH level
between thyroid antibody-positive and thyroid antibody-
negative women who miscarry [27, 28]. In the most recent
meta-analysis, the mean TSH diﬀerence between groups
was 0.61mIU/L (1.7mIU/L versus 1.1mIU/L, P<. 00001)
[28]. Although the TSH levels are well within the normal
range, a 2009 study by Benhadi et al. reported a statistically
signiﬁcantincrease inchildloss(deﬁnedas miscarriage,fetal,
or neonatal death) with increasing levels of TSH between
0.34–5.60mIU/L [29]. Similarly, Negro et al. found a 69%
increase in the rate of miscarriage in thyroid antibody
negative women with TSH values between 2.5–5.0mIU/L as
compared to thyroid antibody negative women with TSH
values below 2.5mIU/L (6.1% versus 3.6%, P = .006)
[30]. Consequently, it is feasible that a component of the
increased risk of pregnancy loss in thyroid antibody positive
women could be attributable to increased TSH levels. On
the other hand, the age diﬀerence reported in the meta-
analysis of 1.3 years (P<. 003) [28] appears to be limited
to explain the marked diﬀerence in pregnancy loss between
thyroid antibody positive and negative women. Insupport of
this contention, Nybo Anderson et al. evaluated pregnancy
outcome in 634,272 women and found only a minimal
increase in the miscarriage rate between maternal ages
20 to 30 and approximately a 1.5%–2.0% increase in the
miscarriage rate for each year between the maternal age of
30 to 40 [31].
Three research groups have evaluated the role of thyroid
antibodies in pregnancy loss in an animal model. In 2001,
Table 2: Country of origin and number of women in each study of
Figure 2.
Author Country TAb+ TAb−
Pratt et al. [9] USA 45 100
Bussen et al. [10] Germany 22 22
Roberts et al. [11]S c o t l a n d1 1 4 1
Bussen et al. [12] Germany 28 28
Esplin et al. [13] USA 74 75
Kutteh et al. [14] USA 700 200
Dendrinos et al. [15] Greece 30 15
Mecacci et al. [16] Italy 29 69
Marai et al. [17]I s r a e l 3 8 2 0
Shoenfeld et al. [18] Italy 33 120
Iravani et al. [19] Iran 64 269
Imaizumi and colleagues evaluated the eﬀect of experi-
mental autoimmune thyroiditis on pregnancy outcome in
a murine model of thyroglobulin immunized female mice
[32]. Autoimmune thyroiditis and pregnancy loss were
enhanced, butonly whenspeciﬁc strains ofmicewere mated.
Class II MHC antigens were found on placental cells from
thyroglobulin inducedmicebutnoton controls.The authors
concluded that the pregnancy loss detected in the murine
model of autoimmune thyroiditis was related to paternal
antigens.
Matalon et al. in 2003 immunized and mated BALB/c
mice with either human thyroglobulin or complete Freund’s
adjuvant (the control group) [33]. No diﬀerence in thyroid
function tests were found between the two groups of mice.
Animals immunized with human thyroglobulin developed
high titers of antithyroglobulin antibodies and antibodies to
thyroglobulin on the placenta. The rate of resorbed fetuses
was higher in the immunized animals. Immunized animals
also had lower placental and fetal weights. Interestingly,
Mannisto et al. reported higher placental weights in thyroid6 Journal of Thyroid Research
peroxidase antibody mothers, but not in thyroglobulin
antibody women [34]. In 2009, Lee et al. reported similar
ﬁndings to Matalon et al. in a study that immunized female
C57bl/6 mice with recombinant mouse thyroid peroxidase
[35]. Compared to controls, immunized mice had a signiﬁ-
cantly higher rate of resorped fetuses and a reduced liter size.
The authors concluded that antithyroid peroxidase antibody
may impact embryo development postimplantation.
To date, the only prospective randomized controlled
treatmentinthyroidantibody-positiveeuthyroidwomenwas
performedbyNegroetal.in2006[8].Therat eofmis carriage
was compared between 57 thyroid peroxidase antibody
women who were given levothyroxine beginning in the ﬁrst
trimester of pregnancy with 58 euthyroid thyroid antibody
positive women who were not given levothyroxine (the
control group). As noted earlier, the dose of levothyroxine
administered was based on a combination of initial TSH
level and titer of thyroid antibody. A statistically signiﬁcant
decrease in spontaneous miscarriage was seen in the group
of treated women as compared to the controls (3.5% versus
13.8%, P<. 05).
5. FutureDirections
Summarizing the studies which have been published over
the last generation, the following can be concluded: (1)
thyroid antibody positivity is associated with pregnancy loss
in unselected pregnancies, (2) thyroid antibody positivity is
associatedwithpregnancy lossinwomenwithrecurrentmis-
carriage, (3) murine data have demonstrated a direct impact
of immunization of female mice, with either thyroglobulin
or thyroid peroxidase, and the development of thyroid
antibodies along with decreased litter size, fetal resorption,
and diminished placental weight, and (4) the results of the
study by Negro et al. demonstrating a decreased rate of preg-
nancy loss in euthyroid thyroid antibody-positive women
are exciting initial data but need to be replicated. Future
directions should include the following: (1) an expansion
of the murine model in order to further elucidate potential
pathophysiologicaletiologies,(2)studiesofimmunemarkers
in thyroid antibody-positive pregnant women, (3) studies of
placentas of thyroid antibody positive pregnant women who
miscarry, (4)studies further separating the impact of thyroid
antibodies and TSH diﬀerences (within the reported normal
range for pregnancy) on miscarriage, and (5) replication
of the study by Negro et al. Many answers should be
forthcoming in the generation ahead.
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